The Annals
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 28 November 2006, www.theannals.com, DOI 10.1345/aph.1H380.
The Annals of Pharmacotherapy: Vol. 40, No. 12, pp. 2276-2277. DOI 10.1345/aph.1H380
© 2006 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Dijk, E. A
Right arrow Articles by De Smet, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Dijk, E. A
Right arrow Articles by De Smet, P. A.

Dosage Adjustments According to Renal Function at Discharge: A Comparison of 3 Hospitals

Elisabeth A van Dijk, PharmD

Head of Pharmacy VieCuri Medical Centre PO Box 1926 5900 BX Venlo, Netherlands fax 31-77-320 6001 lvdijk{at}viecuri.nl Department of Medical Informatics Radboud University Nijmegen Nijmegen, Netherlands

Nathalie RG Drabbe, PharmD

Hospital Pharmacist VieCuri Medical Centre Venlo, Netherlands

Martine Kruijtbosch, MSc

SIR Institute for Pharmacy Practice Research Leiden, Netherlands

Peter AGM De Smet, PharmD PhD

Department of Clinical Pharmacy Radboud University Nijmegen Scientific Institute Dutch Pharmacists The Hague, Netherlands

Published Online, November 28, 2006. www.theannals.com, DOI 10.1345/aph.1H380


TO THE EDITOR: Previously, we investigated the incidence of required versus implemented dosage adjustments in renal failure at discharge.1 We found that necessary dosage adjustments were not performed in our hospital according to generally used guidelines for patients with creatinine clearance less than 51 mL/min/1.73 m2 in over 40% of the cases. The risk of not adjusting the dosage was significantly associated with lower creatinine clearance and greater clinical need of adjusting drug dosage (p < 0.05). Because these findings were counterintuitive, we investigated whether or not this finding was unique to our hospital. We therefore repeated our study in 2 other hospitals in 2 different geographic areas.

Methods. Additional data were collected from the Deventer Ziekenhuis, in Deventer, and Medisch Spectrum Twente, in Enschede, both regional teaching hospitals in the Netherlands. Neither hospital regularly monitored kidney function in relation to drug therapy during admission or at discharge. Medication records of all patients discharged through the discharge counseling service were screened for 30 days between April and May 2006 and analyzed as previously.1

Results. During the stated period, 252 and 299 patients, respectively, were discharged from the hospitals in Deventer and Enschede. Because there were no statistical differences in patient characteristics, the groups were combined for analysis. Nearly 31% (169) of the patients had a calculated creatinine clearance less than 51 mL/min/1.73 m2. These patients received 1106 medications. In 281 (25.4%) prescriptions, dosage adjustment was required according to renal function. This adjustment was made in 160 (56.9%) prescriptions. The other 121 (43.1%) drugs, representing the cases, were not adjusted.

There were no significant differences between cases and controls with respect to the variables of age, sex, duration of hospital stay, number of prescriptions, or physician specialty. Low creatinine clearance levels (<35 mL/min/1.73 m2) significantly increased the risk that a dosage adjustment was not performed (p < 0.05). The same association was found when the clinical relevance of the dosage adjustment was moderately severe or severe (Table 1).


View this table:
[in this window]
[in a new window]

 
Table 1. Determinants of Dosage Adjustments in Cases Versus Controlsa

 

Discussion. In our research population at discharge, 25.4% of all prescribed drugs needed dosage adjustment according to renal function, which is comparable to the percentage (23.9%) we found previously.1 In 56.9% of the prescriptions needing adjustment, doses were adjusted according to guidelines; however, in 43.1% of the prescriptions needing adjustment, the standard dosage remained. Dosage adjustments were most often overlooked in the same drugs (eg, digoxin, metformin, angiotensin-converting enzyme inhibitors). These data are comparable to those of our previous study (Table 1).1

The same significant associations were found in relation to renal function and clinical need for adjustment. Worsening renal function (creatinine clearance <35 mL/min/1.73 m2) was associated with unperformed dosage adjustments (OR 0.413), which is comparable to the results found earlier (OR 0.47).1 The association between the consequences of nonadjustment and dosage adjustment per guidelines was exactly the same in both studies (OR 2.41). Therefore, we conclude that there are no geographical differences in the adjustment of drug dosage according to renal function at discharge.

In the studied population, although dosage adjustments were necessary in 25% of all prescriptions, they were performed in only 57% of those needed. The risk of not adjusting the dosage was significantly associated with a creatinine clearance of <35 mL/min/1.73 m2 and the necessity of dosage adjustments (p < 0.05), which duplicated earlier results. The similar findings and associations in different hospitals subscribe to the need for uniformity in dosing guidelines and the development of a general dynamic alert system as a tool to adapt drug dosing in patients with renal impairment.

Acknowledgments

We thank C Neef PharmD PhD, clinical pharmacologist, and I van Berlo-de Laar PharmD, clinical pharmacist, for offering insight into the medication records at discharge in their hospitals.

References

  1. van Dijk EA, Drabbe NRG, Kruijtbosch M, De Smet PAGM. Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother 2006;40:1254-60. Epub 27 Jun 2006. DOI10.1345/aph.1G742[Abstract/Free Full Text]




This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Dijk, E. A
Right arrow Articles by De Smet, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Dijk, E. A
Right arrow Articles by De Smet, P. A.


homecopy help contact us subscription past issues search current issue